Literature DB >> 15691574

Clinical phenotypes in carriers of Leber congenital amaurosis mutations.

Jennifer A Galvin1, Gerald A Fishman, Edwin M Stone, Robert K Koenekoop.   

Abstract

OBJECTIVE: To determine the clinical phenotypes in carriers with probable disease-causing sequence variations in 1 of 6 genes established to cause Leber congenital amaurosis (LCA).
DESIGN: Observational prospective comparative study. PARTICIPANTS: Thirty carriers with various probable disease-causing sequence variations in 1 of 6 genes known to cause LCA.
METHODS: After the establishment of various disease-causing sequence variations in 37 (33.6%) of 110 patients with LCA, we examined a number of carriers who were either parents or offspring and who were willing to participate in our study. Evaluations included assessment of visual acuity, slit-lamp biomicroscopy, dilated fundus examination, and full-field electroretinogram (ERG) measurements. MAIN OUTCOME MEASURES: Dilated fundus examination and full-field ERGs.
RESULTS: Of the 30 carriers with probable disease-causing sequence variations for LCA, 5 (16.7%) carriers had an AIPL1 variation, 4 (13.3%) CRB1, 0 (0%) CRX, 5 (16.7%) GUCY2D, 9 (30%) RPE65, and 7 (23.3%) carriers had a RPGRIP1 variation. Twenty-nine (96.7%) carriers had 20/20 or better visual acuity in their better seeing eye with correction. Drusenlike deposits were more selectively observed in carriers with mutations in the AIPL1, CRB1, RPE65, and RPGRIP1 genes, whereas mild peripheral chorioretinal atrophy was only observed in AIPL1 and RPE65 carriers. A reduced dark-adapted isolated rod ERG response and/or maximal combined cone and rod response was recorded in carriers with mutations in the AIPL1, GUCY2D, and RPGRIP1 genes. A reduced light-adapted ERG response to a single-flash and/or 32-Hz flicker was recorded in carriers with mutations in the AIPL1, CRB1, GUCY2D, and RPGRIP1 genes. Overall, our cohort of LCA carriers did not describe significant subjective visual difficulties, including nyctalopia and/or photosensitivity.
CONCLUSIONS: The variation of phenotypic expression in carriers among 5 LCA genotypes indicates that there is considerable phenotypic overlap. However, phenotypic trends were noted in carriers' fundus findings and ERG responses for each genetic subtype. Observations of phenotypic associations with specific disease-causing sequence variations in carriers have potential practical value for molecular screening strategies of patients with LCA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691574     DOI: 10.1016/j.ophtha.2004.08.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

2.  Comprehensive Molecular Diagnosis of a Large Chinese Leber Congenital Amaurosis Cohort.

Authors:  Hui Wang; Xia Wang; Xuan Zou; Shan Xu; Hui Li; Zachry Tore Soens; Keqing Wang; Yumei Li; Fangtian Dong; Rui Chen; Ruifang Sui
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

3.  Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma.

Authors:  Lorena Fernández-Martínez; Stef Letteboer; Christian Y Mardin; Nicole Weisschuh; Eugen Gramer; Bernhard Hf Weber; Bernd Rautenstrauss; Paulo A Ferreira; Friedrich E Kruse; André Reis; Ronald Roepman; Francesca Pasutto
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

Review 4.  Leber congenital amaurosis caused by mutations in RPGRIP1.

Authors:  Tiansen Li
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-20       Impact factor: 6.915

5.  Clinical and genetic characteristics of Leber congenital amaurosis with novel mutations in known genes based on a Chinese eastern coast Han population.

Authors:  Shiyuan Wang; Qi Zhang; Xiang Zhang; Zhaoyang Wang; Peiquan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-16       Impact factor: 3.117

6.  Impact of retinal disease-associated RPE65 mutations on retinoid isomerization.

Authors:  Grzegorz Bereta; Philip D Kiser; Marcin Golczak; Wenyu Sun; Elise Heon; David A Saperstein; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2008-08-23       Impact factor: 3.162

Review 7.  Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.

Authors:  Albert M Maguire; Jean Bennett; Elena M Aleman; Bart P Leroy; Tomas S Aleman
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

Review 8.  An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.

Authors:  Wei Chiu; Ting-Yi Lin; Yun-Chia Chang; Henkie Isahwan-Ahmad Mulyadi Lai; Shen-Che Lin; Chun Ma; Aliaksandr A Yarmishyn; Shiuan-Chen Lin; Kao-Jung Chang; Yu-Bai Chou; Chih-Chien Hsu; Tai-Chi Lin; Shih-Jen Chen; Yueh Chien; Yi-Ping Yang; De-Kuang Hwang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

9.  Bax-induced apoptosis in Leber's congenital amaurosis: a dual role in rod and cone degeneration.

Authors:  Séverine Hamann; Daniel F Schorderet; Sandra Cottet
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.